Back to search

Article

Effectiveness and safety of artemether–lumefantrine and dihydroartemisinin– piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Franceville, Gabon

2026-08-31

Abstract excerpt

<title>Abstract</title> <p> <bold>Background</bold> Artemether-lumefantrine (AL) and dihydroartemisinin-piperaquine (DHAPPQ) are the currently recommended first and second-line treatment for uncomplicated <italic>Plasmodium falciparum</italic> malaria in Gabon. Since 2017, no study assessing the efficacy of Artemisinin-based combinations (ACTs) was performed in Gabon, despite emerging signs of reduced efficac...

Identifiers and source

Literature Corpus work
2852b7e3-7a18-5fbf-9cb6-38694cc2d6a5
DOI
10.21203/rs.3.rs-10751967/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Effectiveness and safety of artemether–lumefantrine and dihydroartemisinin– piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Franceville, GabonDOI 10.21203/rs.3.rs-10751967/v1
Clinical Efficacy and Safety of Artemisinin-based Combination Therapies in the Treatment of Uncomplicated Plasmodium Falciparum Malaria in Cameroon: A Systematic Review and Meta-Analysis from Individual Patient Data (2004-2020)Semantic proximity
Efficacy and Safety of Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine for The Treatment of Uncomplicated Plasmodium Falciparum Malaria and Prevalence of Molecular Markers Associated With Artemisinin and Partner Drug Resistance in UgandaSemantic proximity
The transmission blocking activity of artemisinin-combination, non-artemisinin, and 8-aminoquinoline antimalarial therapies: a pooled analysis of individual participant dataSemantic proximity
Therapeutic efficacy of artesunate–amodiaquine and artemether–lumefantrine for the treatment of uncomplicated falciparum malaria in Chad: clinical and genetic surveillanceSemantic proximity
Characterization of Plasmodium falciparum resistance genes to common antimalarials in semi-urban areas of Burkina FasoSemantic proximity
Therapeutic Efficacy and Tolerability of Artemether-lumefantrine for Uncomplicated Plasmodium Falciparum Malaria in Niger, 2020Semantic proximity
Molecular Markers of Antimalarial Resistance in Children with Uncomplicated Plasmodium falciparum at Two Sites in Liberia in 2022-2023Semantic proximity
Therapeutic efficacy of artemether-lumefantrine and artesunate-amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Mali, 2015–2016Semantic proximity
Border Region Surveillance of Malaria Drug Resistance, Northern Burundi, 2023-2024.Semantic proximity
Spatio-temporal trends of the prevalence of Plasmodium falciparum antimalarial drug resistance markers across sub-Saharan Africa from 2010 to 2024: a systematic review and meta-analysis.Semantic proximity
Assessing the Therapeutic Efficacy of Artemether-Lumefantrine for Uncomplicated Malaria in Lagos, Nigeria: A Comprehensive Study on Treatment Response and Resistance MarkersSemantic proximity
Prevalence of Plasmodium falciparum antimalarial drug resistance genes in Southeastern Gabon from 2011 to 2014Semantic proximity
Select a neighboring publication to make it the new centre.